SlideShare a Scribd company logo
Presented by
M.Kalyan Sai
Pharm D IV year
16T11T0004
Asphyxia :
The condition where the body either does
not get enough oxygen to continue renal function or
has too much carbondioxide to perform its functions
properly is known as asphyxia.
Asphyxia causes generalized hypoxia.
Fetal Hypoxia :
Intrauterine hypoxia occurs when the fetus
is deprived of an adequate supply of oxygen.
 Mother – Hypoventilation during the anesthesia,
respiratory failure or CO poisoning.
 Premature separation of the placenta. PLACENTA
PREVIA.
 Impedance to the circulation of the blood through
the umbilical cord as a result of compression or
knotting of the cord.
 Uterine vessel constriction by coccaine or smoking.
 Extremes in maternal age (< 20 yrs - >35 yrs).
 Preterm or post term gestation.
Asphyxia with developmental delay and status epileptics
 Frequency of severe birth asphyxia were higher in
makes than females.
Etiology – High Risk Factors :
 Hypoxia
 Nephritis
 Heart Diseases
 Too older or too young
 Anemia
 Diabetes
 Hypertension
 Smoking
Epidemology :
 Responsible for >8,00,000 neonatal deaths per year
in Africa.
 In contrast to developed countries, initial mortality
of severely asphyxiated babies in low income
countries is high and long term survival after birth
asphyxia is low.
 In Nigeria, birth asphyxia occours in 83.5 per 1000
live births and accounted for 25.9% of total neonatal
death with 58.7% of his death occouring within the
first 24hrs after birth.
Pathophysiology : -
Reduction in oxygen tension
Capillary Dilation
Capillary Stasis
Capillary Enlargement
Stasis of blood in organs
Diminished venous return to heart
Reduced pulmonary flow
Deficient oxygen supply in lungs
ASPHYXIA
Factors :
Decrease in maternal oxygenation
decrease in blood flow from mother to placenta
Blood flow decreases from placenta to fetus
Decrease gas exchange across placenta or fetal tissue
Increase in fetal oxygen required.
Status Epilepticus :
It is a dangerous condition in which epileptics
fits follow one another without recovery of
consciousness between them.
Status epilepticus is when a seizure lasts longer
than 5 minutes or seizures occur close together and the
person doesn’t recover between seizures.
It is a very rare condition.
This includes :-
High Fever
Brain infections
Abnormal sodium levels
Abnormal blood sugar levels
Head injuries
May leads to permanent brain damage or death.
Symptoms :
 Muscle Spasms
 Falling
 Confusion
 Unusual noises
 Loss of bowel or bladder control
 Clenched teeth
 Irregular breathing
 Unusual behavior.
 EPIDEMOLOGY :
a) In children, Status Epilepticus occours within 2
years of the onset of epilepsy.
b) Recurrent status epilepticus is usually associated
with underlying neurological disorder.
c) Status Epilepticus is most common in those <2yrs of
age.
d) 25% of patients with status epilepticus have pre-
existing epilepsy.
e) 4-16% of Patients with epilepsy have atleast 1
episode of SE.
Etiology : -
 Stroke, including haemorrhagic
 Alcohol withdrawn
 Anoxic brain injury
 Metabolic disturbances
 Remote brain injury
 Infections
 Brain neoplasms
 Idiopathic
MANAGEMENT :
Aggressive treatment is necessary for status
epilepticus. Clinicians should not wait for blood level
results before administrating a loading dose of
phenytoin regardless of whether the patient is already
taking phenytoin.
Medications used in treatment of SE :
 Benzodiazepines [e.g. – Lorazepam, diazepam,
midazolam] First Line Drugs.
 Anticonvulsant agents [e.g.- Phenytoin, fosphenytoin]
 Barbiturates [e.g.- Phenobarbital, pentobarbital]
 Anesthetics [e.g.- propofol]
Complications of Status Epilepticus :
I- Hypoxia
II- Acidemia
III- Glucose alterations
IV- Blood pressure disturbances
V- Increased intracranial pressure
VI – Respiratory Failure
 Morbidity
- 10% - 20%
- Neurological Sequelae
- Focal motor deficits
- Mental retardation
- Behavioral disorders
- Chronic epilepsy
- Acute or chronic MRI changes
 Mortality
- 3 – 8%
Pharmacological Treatment :
1. First Line Drugs :
- Lorazepam 2-4mg IV
- Diazepam 5-10mg IV
- Midazolam 2-4mg IV [10mg IM]
2. Second Line Drugs :
- Phenytoin or fosphenytoin 20mg/kg IV
- Valproic acid 20mg/kg IV
- Phenobarbital 20mg/kg IV at 50mg/min
3. Third Line Drugs :
- Pentobarbital 5-15 mg/kg
- Propofol 3-5 mg/kg
Asphyxia with developmental delay and status epileptics
A CASE STUDY ON ASPHYXIA WITH
DEVELOPMENTAL DELAY AND STATUS
EPILEPTICUS
SUBJECTIVE
Demographic Details :
A male child patient of age 5
years was admitted in a pediatric ward on 27-4-2019
with the symptoms of seizures.
HPI :
Birth Asphyxia Sensulae with developmental delay
with breakthrough seizures.
SUBJECTIVE
Past Medical History : COMA for a month after
immediate birth.
PAST MEDICATION HISTORY : NIL
Allergies : NIL
OBJECTIVE
PARAMETER VALUE
Pulse Rate 120bpm
Respiratory Rate 24/min
CVS S1 S2 +
CNS Developmental Delay
Respiratory System clear
P/A Soft
LAB INVESTIGATIONS
CT Scan :- Normal
CNS :- Drowsy 1 arousal
Meningial irritation – NO
Neck Stiffness – NO
Glasgow coma Scale – E2 V5 M2
Total Score = 09
ASSESSMENT :
ASPHYXIA WITH DEVELOPMENTAL DELAY AND
STATUS EPILEPTICUS
Asphyxia with developmental delay and status epileptics
DRUGS PRESCRIBED ON ADMISSION
Day – 1
1. O2 inhalation
2. Inj.Midazolam 1.3cc IV stat given & sos
3. Inj.Phenytoin loading dose 260mg IV stat
4. Inj.Ceftriaxone 600mg IV BD
5. IVF DNS 350ml 8th hourly
6. Anamol 180ml sos
Da
y
On examination Pt
complaints
Drug Dose Frequency
2 Vitals stable
CVS – S1 S2 +
RS – BAE+
CNS – NAD
P/A - Soft
No further
seizures
Fever
CST
+
T.Paraceta
mol
500mg
(1/2)
IV BD
TID
SOS
3 Vitals Stable
CVS – NAD
CNS – NAD
RS – NAD
P/A - Soft
No further
seizures
Fever
CST
+
IVF DNS
350ml IV BD
TID
SOS
4 Febrile
CVS – NAD
CNS – NAD
RS – NAD
P/A - Soft
Fever CST
+
Inj.Amikaci
n
200mg IV OD
Da
y
On Examination Pt
Complaint
s
Drug Dose Frequency
5 AFebrile
PR – 120/min
RR – 24/min
CVS – S1S2 +
CNS –
Developmental
Delay
RS – Clear
P/A - Soft
No further
seizures
Fever
Decreased
CST
Stop IVF
SOS
6 &
7
Afebrile
Vitals – Stable
CVS – NAD
RS – NAD
CNS – Conscious
& oriented
P/A - Soft
No Furthur
Seizures
Inj.Ceftriax
one
Inj.Phenyto
in
T. PCT
T. B
Complex
Inj.Amikaci
n
650mg
35mg
½
200mg
IV BD
IV BD
TID
OD
IV OD
MY PLAN
 If seizures continue after 20 mins, give additional
fosphenytoin[10mg/kg IV] or Phenytoin[10mg/kg
IV]. Aim for a total serum phenytoin levels of about
22-25 micrograms/ml.
 Benzodiazepines [e.g. – Lorazepam, diazepam,
midazolam] First Line Drugs.
 Anticonvulsant agents [e.g.- Phenytoin,
fosphenytoin] Second line drugs
 Barbiturates [e.g.- Phenobarbital, pentobarbital]
Third line drugs
 Anesthetics [e.g.- propofol]
INTERVENTIONS :
 Phenytoin + Midazolam = Phenytoin will decrease
the effect of midazolam by affecting
hepatic/intestinal enzymes metabolism.
 Phenytoin or Midazolam + Amikacin = Phenytoin
or Midazolam will decrease the effect of amikacin
by P-glycoprotein efflux transporter.
 SUBJECTIVE :
Past Medical History : COMA for a month after
immediate birth.
PAST MEDICATION HISTORY : NIL
Allergies : NIL
OBJECTIVES :
CT Scan :- Normal
CNS :- Drowsy 1 arousal
Meningial irritation – NO
Neck Stiffness – NO
Glasgow coma Scale – E2 V5 M2
Total Score = 09
 ASSESSMENT :
ASPHYXIA WITH DEVELOPMENTAL DELAY
AND STATUS EPILEPTICUS
RESOLUTION :
 Phenytoin + Midazolam = Phenytoin will decrease
the effect of midazolam by affecting hepatic/intestinal
enzymes metabolism.
 Phenytoin or Midazolam + Amikacin = Phenytoin or
Midazolam will decrease the effect of amikacin by P-
glycoprotein efflux transporter.
 MONITORING :
Phenytoin decreases the effect of midazolam by
affecting the metabolism of intestine enzymes.
Phenytoin or Midazolam will decrease the
effect of amikacin by P-glycoprotein efflux
transporter.
We can control this by regulating the doses
between the drugs.
 Adverse Effects
Midazolam :
 Drowsiness
 Apnea
 Nausea / vomiting
 Seizure like activity
 Pain at injection site
Amikacin :
 Hypotension
 Headache
 Rash
 Nausea / Vomiting
Phenytoin :
 Drowsiness
 Fatigue
 Headache
 Restlessness
 Slurred speech
 Nervousness
Ceftriaxone :
 Diarrhea
 Rash
 Leukopenia
 Thrombocytosis
Non Pharmacological Treatment :
 Should not withdrawn epileptic drugs.
 If any antibiotic given should use total course
 Should maintain a healthy diet
 Contact your health care provider if any seizures
are noticed.
 Ketogenic diet[Chicken, Ginger, onion, tomato,
garlic] should be maintained.
 By following ketogenic diet we can control seizures
nearly upto 50 – 80%.
Asphyxia with developmental delay and status epileptics

More Related Content

PPT
Perinatalasphyxia
PPTX
Neonatal seizures presentation
PPT
12. Curs Asfixia
PPT
Anoxic brain injury
PPTX
Wernicke korsakoff syndrome ppt
PPTX
N. seizure tsn
PPTX
Management of Asphyxia
PPTX
Hypoxic Ischemic Encephalopathy
Perinatalasphyxia
Neonatal seizures presentation
12. Curs Asfixia
Anoxic brain injury
Wernicke korsakoff syndrome ppt
N. seizure tsn
Management of Asphyxia
Hypoxic Ischemic Encephalopathy

What's hot (20)

PPTX
Neonatal seizure (2)
PPTX
Perinatal Asphyxia
PPTX
Birth asphyxia presentation
PPT
Asphyxia neonatorum
PPT
Perinatal asphyxia
PPTX
Birth asphyxia
PPTX
Birth asphyxia 2
PPTX
Hie seminar
PPSX
PPTX
Neonatal seizures
PPTX
Hypoxic ischemic encephalopathy with a focus on recent advances
PPTX
Neonatal seizure basics, classifications and management
PPTX
Birth asphyxia
PPTX
Preterm Neonate
PPTX
Birth asphyxia neurpathology
PPT
Hypoxic ischemic encephalopathy
PPTX
Wernicke’s encephalopathy
PPT
PPTX
Perinatal asphyxia
Neonatal seizure (2)
Perinatal Asphyxia
Birth asphyxia presentation
Asphyxia neonatorum
Perinatal asphyxia
Birth asphyxia
Birth asphyxia 2
Hie seminar
Neonatal seizures
Hypoxic ischemic encephalopathy with a focus on recent advances
Neonatal seizure basics, classifications and management
Birth asphyxia
Preterm Neonate
Birth asphyxia neurpathology
Hypoxic ischemic encephalopathy
Wernicke’s encephalopathy
Perinatal asphyxia
Ad

Similar to Asphyxia with developmental delay and status epileptics (20)

PPTX
STATUS EPILEPTICUS.pptx
PPT
Deepak seminar on status epilepticus
PPTX
The seizing patient
PPTX
Status epileticus by dr shoaib hameed lone childern
PPTX
Mgt of Status epilepticus and it's component.pptx
PPTX
pediatric statrus epilepticus final.pptx
PPTX
Status epilapticus
PPTX
Status Epileptikus Tatalaksana JogjaNeeds
PPT
Status epilapticus
PDF
Management of Status Epilepticus
PPTX
NEW GUIDELINES FOR Status epilepticus
PPTX
STATUS EPILEPTICUS AND RAISED ICP Pediatrics.pptx
PPTX
Status epilepticus
PPT
Management of status epilepticus in children
PPTX
Approach to seizure disorder
PPT
Status epilapticus print
PPTX
status epilepticus zaira hussain panhwar.pptx
 
PPTX
Status epilapticus
DOC
Status Epilepticus
PPT
status epilepticus
STATUS EPILEPTICUS.pptx
Deepak seminar on status epilepticus
The seizing patient
Status epileticus by dr shoaib hameed lone childern
Mgt of Status epilepticus and it's component.pptx
pediatric statrus epilepticus final.pptx
Status epilapticus
Status Epileptikus Tatalaksana JogjaNeeds
Status epilapticus
Management of Status Epilepticus
NEW GUIDELINES FOR Status epilepticus
STATUS EPILEPTICUS AND RAISED ICP Pediatrics.pptx
Status epilepticus
Management of status epilepticus in children
Approach to seizure disorder
Status epilapticus print
status epilepticus zaira hussain panhwar.pptx
 
Status epilapticus
Status Epilepticus
status epilepticus
Ad

Recently uploaded (20)

PPTX
Neuropathic pain.ppt treatment managment
PPTX
CME 2 Acute Chest Pain preentation for education
PPTX
ACID BASE management, base deficit correction
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPT
ASRH Presentation for students and teachers 2770633.ppt
PPT
Obstructive sleep apnea in orthodontics treatment
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPTX
Cardiovascular - antihypertensive medical backgrounds
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPTX
Respiratory drugs, drugs acting on the respi system
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPTX
Clinical approach and Radiotherapy principles.pptx
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
Neuropathic pain.ppt treatment managment
CME 2 Acute Chest Pain preentation for education
ACID BASE management, base deficit correction
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
ASRH Presentation for students and teachers 2770633.ppt
Obstructive sleep apnea in orthodontics treatment
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
Cardiovascular - antihypertensive medical backgrounds
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
Respiratory drugs, drugs acting on the respi system
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
Clinical approach and Radiotherapy principles.pptx
Medical Evidence in the Criminal Justice Delivery System in.pdf

Asphyxia with developmental delay and status epileptics

  • 1. Presented by M.Kalyan Sai Pharm D IV year 16T11T0004
  • 2. Asphyxia : The condition where the body either does not get enough oxygen to continue renal function or has too much carbondioxide to perform its functions properly is known as asphyxia. Asphyxia causes generalized hypoxia.
  • 3. Fetal Hypoxia : Intrauterine hypoxia occurs when the fetus is deprived of an adequate supply of oxygen.  Mother – Hypoventilation during the anesthesia, respiratory failure or CO poisoning.  Premature separation of the placenta. PLACENTA PREVIA.  Impedance to the circulation of the blood through the umbilical cord as a result of compression or knotting of the cord.  Uterine vessel constriction by coccaine or smoking.
  • 4.  Extremes in maternal age (< 20 yrs - >35 yrs).  Preterm or post term gestation.
  • 6.  Frequency of severe birth asphyxia were higher in makes than females. Etiology – High Risk Factors :  Hypoxia  Nephritis  Heart Diseases  Too older or too young  Anemia  Diabetes  Hypertension  Smoking
  • 7. Epidemology :  Responsible for >8,00,000 neonatal deaths per year in Africa.  In contrast to developed countries, initial mortality of severely asphyxiated babies in low income countries is high and long term survival after birth asphyxia is low.  In Nigeria, birth asphyxia occours in 83.5 per 1000 live births and accounted for 25.9% of total neonatal death with 58.7% of his death occouring within the first 24hrs after birth.
  • 8. Pathophysiology : - Reduction in oxygen tension Capillary Dilation Capillary Stasis Capillary Enlargement Stasis of blood in organs
  • 9. Diminished venous return to heart Reduced pulmonary flow Deficient oxygen supply in lungs ASPHYXIA
  • 10. Factors : Decrease in maternal oxygenation decrease in blood flow from mother to placenta Blood flow decreases from placenta to fetus Decrease gas exchange across placenta or fetal tissue Increase in fetal oxygen required.
  • 11. Status Epilepticus : It is a dangerous condition in which epileptics fits follow one another without recovery of consciousness between them. Status epilepticus is when a seizure lasts longer than 5 minutes or seizures occur close together and the person doesn’t recover between seizures. It is a very rare condition. This includes :- High Fever Brain infections Abnormal sodium levels Abnormal blood sugar levels Head injuries May leads to permanent brain damage or death.
  • 12. Symptoms :  Muscle Spasms  Falling  Confusion  Unusual noises  Loss of bowel or bladder control  Clenched teeth  Irregular breathing  Unusual behavior.
  • 13.  EPIDEMOLOGY : a) In children, Status Epilepticus occours within 2 years of the onset of epilepsy. b) Recurrent status epilepticus is usually associated with underlying neurological disorder. c) Status Epilepticus is most common in those <2yrs of age. d) 25% of patients with status epilepticus have pre- existing epilepsy. e) 4-16% of Patients with epilepsy have atleast 1 episode of SE.
  • 14. Etiology : -  Stroke, including haemorrhagic  Alcohol withdrawn  Anoxic brain injury  Metabolic disturbances  Remote brain injury  Infections  Brain neoplasms  Idiopathic
  • 15. MANAGEMENT : Aggressive treatment is necessary for status epilepticus. Clinicians should not wait for blood level results before administrating a loading dose of phenytoin regardless of whether the patient is already taking phenytoin. Medications used in treatment of SE :  Benzodiazepines [e.g. – Lorazepam, diazepam, midazolam] First Line Drugs.  Anticonvulsant agents [e.g.- Phenytoin, fosphenytoin]  Barbiturates [e.g.- Phenobarbital, pentobarbital]  Anesthetics [e.g.- propofol]
  • 16. Complications of Status Epilepticus : I- Hypoxia II- Acidemia III- Glucose alterations IV- Blood pressure disturbances V- Increased intracranial pressure VI – Respiratory Failure
  • 17.  Morbidity - 10% - 20% - Neurological Sequelae - Focal motor deficits - Mental retardation - Behavioral disorders - Chronic epilepsy - Acute or chronic MRI changes  Mortality - 3 – 8%
  • 18. Pharmacological Treatment : 1. First Line Drugs : - Lorazepam 2-4mg IV - Diazepam 5-10mg IV - Midazolam 2-4mg IV [10mg IM] 2. Second Line Drugs : - Phenytoin or fosphenytoin 20mg/kg IV - Valproic acid 20mg/kg IV - Phenobarbital 20mg/kg IV at 50mg/min 3. Third Line Drugs : - Pentobarbital 5-15 mg/kg - Propofol 3-5 mg/kg
  • 20. A CASE STUDY ON ASPHYXIA WITH DEVELOPMENTAL DELAY AND STATUS EPILEPTICUS
  • 21. SUBJECTIVE Demographic Details : A male child patient of age 5 years was admitted in a pediatric ward on 27-4-2019 with the symptoms of seizures. HPI : Birth Asphyxia Sensulae with developmental delay with breakthrough seizures.
  • 22. SUBJECTIVE Past Medical History : COMA for a month after immediate birth. PAST MEDICATION HISTORY : NIL Allergies : NIL
  • 23. OBJECTIVE PARAMETER VALUE Pulse Rate 120bpm Respiratory Rate 24/min CVS S1 S2 + CNS Developmental Delay Respiratory System clear P/A Soft
  • 24. LAB INVESTIGATIONS CT Scan :- Normal CNS :- Drowsy 1 arousal Meningial irritation – NO Neck Stiffness – NO Glasgow coma Scale – E2 V5 M2 Total Score = 09 ASSESSMENT : ASPHYXIA WITH DEVELOPMENTAL DELAY AND STATUS EPILEPTICUS
  • 26. DRUGS PRESCRIBED ON ADMISSION Day – 1 1. O2 inhalation 2. Inj.Midazolam 1.3cc IV stat given & sos 3. Inj.Phenytoin loading dose 260mg IV stat 4. Inj.Ceftriaxone 600mg IV BD 5. IVF DNS 350ml 8th hourly 6. Anamol 180ml sos
  • 27. Da y On examination Pt complaints Drug Dose Frequency 2 Vitals stable CVS – S1 S2 + RS – BAE+ CNS – NAD P/A - Soft No further seizures Fever CST + T.Paraceta mol 500mg (1/2) IV BD TID SOS 3 Vitals Stable CVS – NAD CNS – NAD RS – NAD P/A - Soft No further seizures Fever CST + IVF DNS 350ml IV BD TID SOS 4 Febrile CVS – NAD CNS – NAD RS – NAD P/A - Soft Fever CST + Inj.Amikaci n 200mg IV OD
  • 28. Da y On Examination Pt Complaint s Drug Dose Frequency 5 AFebrile PR – 120/min RR – 24/min CVS – S1S2 + CNS – Developmental Delay RS – Clear P/A - Soft No further seizures Fever Decreased CST Stop IVF SOS 6 & 7 Afebrile Vitals – Stable CVS – NAD RS – NAD CNS – Conscious & oriented P/A - Soft No Furthur Seizures Inj.Ceftriax one Inj.Phenyto in T. PCT T. B Complex Inj.Amikaci n 650mg 35mg ½ 200mg IV BD IV BD TID OD IV OD
  • 29. MY PLAN  If seizures continue after 20 mins, give additional fosphenytoin[10mg/kg IV] or Phenytoin[10mg/kg IV]. Aim for a total serum phenytoin levels of about 22-25 micrograms/ml.  Benzodiazepines [e.g. – Lorazepam, diazepam, midazolam] First Line Drugs.  Anticonvulsant agents [e.g.- Phenytoin, fosphenytoin] Second line drugs  Barbiturates [e.g.- Phenobarbital, pentobarbital] Third line drugs  Anesthetics [e.g.- propofol]
  • 30. INTERVENTIONS :  Phenytoin + Midazolam = Phenytoin will decrease the effect of midazolam by affecting hepatic/intestinal enzymes metabolism.  Phenytoin or Midazolam + Amikacin = Phenytoin or Midazolam will decrease the effect of amikacin by P-glycoprotein efflux transporter.
  • 31.  SUBJECTIVE : Past Medical History : COMA for a month after immediate birth. PAST MEDICATION HISTORY : NIL Allergies : NIL OBJECTIVES : CT Scan :- Normal CNS :- Drowsy 1 arousal Meningial irritation – NO Neck Stiffness – NO Glasgow coma Scale – E2 V5 M2 Total Score = 09
  • 32.  ASSESSMENT : ASPHYXIA WITH DEVELOPMENTAL DELAY AND STATUS EPILEPTICUS RESOLUTION :  Phenytoin + Midazolam = Phenytoin will decrease the effect of midazolam by affecting hepatic/intestinal enzymes metabolism.  Phenytoin or Midazolam + Amikacin = Phenytoin or Midazolam will decrease the effect of amikacin by P- glycoprotein efflux transporter.
  • 33.  MONITORING : Phenytoin decreases the effect of midazolam by affecting the metabolism of intestine enzymes. Phenytoin or Midazolam will decrease the effect of amikacin by P-glycoprotein efflux transporter. We can control this by regulating the doses between the drugs.
  • 34.  Adverse Effects Midazolam :  Drowsiness  Apnea  Nausea / vomiting  Seizure like activity  Pain at injection site Amikacin :  Hypotension  Headache  Rash  Nausea / Vomiting
  • 35. Phenytoin :  Drowsiness  Fatigue  Headache  Restlessness  Slurred speech  Nervousness Ceftriaxone :  Diarrhea  Rash  Leukopenia  Thrombocytosis
  • 36. Non Pharmacological Treatment :  Should not withdrawn epileptic drugs.  If any antibiotic given should use total course  Should maintain a healthy diet  Contact your health care provider if any seizures are noticed.  Ketogenic diet[Chicken, Ginger, onion, tomato, garlic] should be maintained.  By following ketogenic diet we can control seizures nearly upto 50 – 80%.